Recent News

By Category: Countermeasures

NIH scientists, grantees map possible path to an HIV vaccine

(EurekAlert) In an advance for HIV vaccine research, scientists have for the first time determined how both the virus and a resulting strong antibody response co-evolved in one HIV-infected individual. The findings could help researchers identify which proteins to use in investigational vaccines to induce antibodies capable of preventing infection from an array of HIV Read More »

April 4, 2013
| Filed under North America, Countermeasures, and Research
Share

Can Repurposed Cancer Drugs Counter Bioterror Threats?

(ScienceDaily) A Saint Louis University researcher has received a contract worth up to $980,000 to see if two cancer medications have the potential of protecting U.S. troops from biological agents that could be unleashed during an attack.

April 4, 2013
| Filed under North America, Countermeasures, and Public Health
Share

New Foot and Mouth vaccine – BBC News

New Foot and Mouth vaccineBBC NewsResearchers based in the UK have developed a new type of vaccine for the cattle disease Foot and Mouth. As the new vaccine is not based on a live virus it is much easier to distinguish between vaccinated animals and those infected with the disease.New vaccine for foot and mouth Read More »

April 4, 2013
| Filed under Countermeasures
Share

New promise for an HIV vaccine as researchers overcome crucial obstacle

(ScienceDaily) In a crucial step towards developing a successful HIV vaccine, researchers have been able, for the first time, to stimulate immune cells that can produce broadly neutralizing antibodies: a feat that has eluded vaccine researchers for decades. The exciting results are published in this month’s issue of the Journal of Experimental Medicine.

April 3, 2013
| Filed under North America, Countermeasures, and Research
Share

NIH-Supported Researchers Identify New Class of Malaria Compounds

(GlobalBiodefense) A group of researchers from 16 institutions around the world has identified a new class of anti-malarial compounds that target multiple stages of the malaria parasite’s life cycle. These compounds could potentially be developed into drugs that treat and prevent malaria infection. Known as 4-(1H)-quinolone-3-diarylethers, the candidate anti-malarials are derived from a compound called Read More »